"Saccharomyces boulardii" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.
Descriptor ID |
D000069983
|
MeSH Number(s) |
B01.300.107.795.785.400 B01.300.930.705.328
|
Concept/Terms |
Saccharomyces boulardii- Saccharomyces boulardii
- Saccharomyces boulardius
- boulardii, Saccharomyces
- boulardius, Saccharomyces
|
Below are MeSH descriptors whose meaning is more general than "Saccharomyces boulardii".
Below are MeSH descriptors whose meaning is more specific than "Saccharomyces boulardii".
This graph shows the total number of publications written about "Saccharomyces boulardii" by people in this website by year, and whether "Saccharomyces boulardii" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 3 | 1 | 4 |
2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Saccharomyces boulardii" by people in Profiles.
-
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial. ESC Heart Fail. 2018 10; 5(5):977-984.
-
Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly. Gastroenterology. 2017 11; 153(5):1450-1451.
-
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One. 2017; 12(7):e0181863.
-
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. PLoS One. 2017; 12(4):e0173802.
-
Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses. 2017 Jun; 60(6):375-380.